<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 24, 2000
INSMED INCORPORATED
(Exact name of registrant as specified in its charter)
VIRGINIA 0-30739 54-1972729
--------------------------------- ------------ ----------
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation) Identification No.)
800 East Leigh Street, Richmond, VA 23219
(Address of principal executive offices and zip code)
Registrant's telephone number, including area code: (804) 828-6893
<PAGE>
ITEM 5. OTHER EVENTS
On November 24, 2000, Insmed Incorporated publicly announced that it
had received preliminary data for two clinical trials. This
information is included in the press release attached hereto as
Exhibit 99.1 which was posted on Insmed's website on November 27,
2000.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND
EXHIBITS
(c) Exhibit
99.1 Press Release dated November 24, 2000.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
INSMED INCORPORATED
Date: November 22, 2000 By: /s/ Michael D. Baer
-------------------
Michael D. Baer
Chief Financial Officer
<PAGE>
INSMED INCORPORATED
INDEX TO EXHIBITS
Exhibit Number
99.1 Press Release dated November 24, 2000.
